Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through a NF-κB-independent and ERK-dependent pathway

Oral Oncol. 2013 Dec;49(12):1113-20. doi: 10.1016/j.oraloncology.2013.08.008. Epub 2013 Sep 25.

Abstract

Objectives: Ikappa B kinase alpha (IKKα) plays an inhibitory role in the development of epithelial-derived tumors. However, its specific function in the development of nasopharyngeal carcinoma (NPC) remains unknown. In this study we identify the role and mechanism of IKKα in IKKα-mediated NPC development.

Material and methods: The effect of IKKα on migration, invasion and tumorigenesis of NPC cell lines was determined using in vitro and in vivo studies. SUNE-1-5-8F cells transfected to overexpress IKKα, SUNE-1-6-10B cells with shRNA-mediated knockdown of IKKα, and three NPC cell lines were studied using Western blotting techniques to compare the major molecules in NF-κB pathways. Additionally, the extracellular signal-regulated kinase (ERK) pathway and matrix metalloproteinases (MMPs) in IKKα-regulated NPC and the effect of Epstein-Barr Nuclear Antigen 1 (EBNA1) on IKKα were examined.

Results: IKKα was underexpressed in highly invasive SUNE-1-5-8F cells compared with non-invasive cells (SUNE-1 and SUNE-6-10B). Overexpression of IKKα in SUNE-1-5-8F cells was achieved through transfection and resulted in inhibited migration and invasion in vitro. Furthermore, IKKα inhibited tumorigenesis in mice inoculated with IKKα-transfected NPC cells in vivo. These processes were independent of the conventional effect of IKKα on Nuclear factor κB (NF-κB) pathways. The ERK pathway was involved in IKKα-related NPC inhibition. Phosphorylation of ERK1/2 and subsequent secretion of MMP-9 were inhibited by the ERK inhibitor U0126 and not regulated by overexpressed IKKα. EBNA1 knockdown using small interfering RNA (siRNA) did not alter the expression of IKKα.

Conclusion: Increase in IKKα expression suppresses the progression of NPC through a NF-κB-independent and ERK-dependent pathway.

Keywords: Alternative NF-κB; ERK; Ikappa B kinase alpha; NF-κB; Nasopharyngeal carcinoma; Non-canonical NF-κB; Tumor suppressor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Carcinoma
  • Cell Line, Tumor
  • Epstein-Barr Virus Nuclear Antigens / pharmacology
  • Humans
  • I-kappa B Kinase / drug effects
  • I-kappa B Kinase / metabolism*
  • MAP Kinase Signaling System / physiology
  • Male
  • Matrix Metalloproteinases / metabolism
  • Mice
  • NF-kappa B / metabolism
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms / metabolism*
  • Phosphorylation

Substances

  • Epstein-Barr Virus Nuclear Antigens
  • NF-kappa B
  • I-kappa B Kinase
  • Matrix Metalloproteinases